University of Birmingham: Pioneering Trial to Ensure Arthritis Treatment Suitable for Cancer Immunotherapy Patients
February 17, 2026
February 17, 2026
BIRMINGHAM, England, Feb. 17 -- The University of Birmingham posted the following news:
* * *
Pioneering trial to ensure arthritis treatment suitable for cancer immunotherapy patients
First trial in UK to ensure anti-TNF therapy works for patients who take or have taken checkpoint inhibitor treatments of cancer now open for recruitment
*
Cancer patients being treated with immunotherapy called checkpoint inhibitors often experience . . .
* * *
Pioneering trial to ensure arthritis treatment suitable for cancer immunotherapy patients
First trial in UK to ensure anti-TNF therapy works for patients who take or have taken checkpoint inhibitor treatments of cancer now open for recruitment
*
Cancer patients being treated with immunotherapy called checkpoint inhibitors often experience . . .